Arch Venture Fund IX reported a 4.6% stake in Beam Therapeutics BEAM · 4,600,747 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 4.6%
Last report: 5.6% · filed 25/02/14
Shares held: 4,600,747 sh
Class: Common Stock par value $0.01 per share
Stock: Beam Therapeutics BEAM
Holder: Arch Venture Fund IX
Event date: 25/03/31
Filed: 25/05/15

4.6% stake · below 5%

Stake: 4.6%
Last report: 5.6%
Since last report: −1.0pp

Beam Therapeutics trades, last 26 weeks

What else happened in Beam Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

Arch Venture Fund IX's other 5% stake reports

Arch Venture Fund IX
5% stakeSana Biotechnology
5% stake
Sana Biotechnology
SANA
15.4% stake
46,173,125 sh
15.4% stake
Filed 08/14
Arch Venture Fund IX
5% stakeVir Biotechnology
5% stake
Vir Biotechnology
VIR
8.5% stake
13,534,704 sh
8.5% stake
Filed 03/03

Arch Venture Fund IX reported a 4.6% stake in Beam Therapeutics BEAM · 4,600,747 sh · amendment · passive holder | Whalegun